Ma réponse à ceux qui cherchent à organiser la couverture publique des médicaments selon les intérêts des compagnies d’assurance plutôt que selon l’intérêt de la population. lapresse.ca/dialogue/opini… #pharmacare #insurance Ghost Management Research Group Canada's Nurses @FPACarleton Carleton SPPA

White House Takes Additional Steps Towards Fairer Pricing for Drugs Developed With Taxpayer Funding citizen.org/news/white-hou…

Access to Rx drugs in Canada. Poll finds nearly 1 in 4 Canadian report skipping doses, splitting pills, or not filling prescriptions due to cost - 2 largest health charity patient organizations call on federal government to table pharmacare now cancer.ca/en/about-us/me…

22% des Canadiens ont coupé leurs comprimés, sauté des doses ou n’ont pas renouvelé une ordonnance pour économiser. ledevoir.com/societe/807195…

With only 3,280 words above what I committed, I have a new book manuscript!! Now, it is time to polish 💅 and re-read again and again and again. Verso Books

Join Marc-André Gagnon, @FafardPatrick, Christabelle Sethna and Vanessa Gruben for a lunchtime sem/webinar looking at Canada's new national pharmacare plan. Monday March 4 11:30 am. Hosted by @ottawahealthlaw uOttawa | COMMON LAW Université d'Ottawa | University of Ottawa. All welcome! ottawahealthlaw.ca/events/pharmac…

Joignez-vous à Marc-André Gagnon, @FafardPatrick, Christabelle Sethna et Vanessa Gruben pour un séminaire/webinaire « Exploring Canada's New Pharmacare Program » le lundi 4 mars à 11 h 30. Organisé par @ottawahealthlaw uOttawa | COMMON LAW Université d'Ottawa | University of Ottawa. ottawahealthlaw.ca/events/pharmac…

Just dropped our paper like it's hot!💥 Our deep dive into ClinicalTrials.gov spills the tea on these trials, with a Canadian twist, comparing industry-funded vs. non-industry-funded trials. We did some manual scavenger hunt in the medical lit ✨ 📄ijhpm.com/article_4576.h…

Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health frontiersin.org/articles/10.33… Frontiers Medicine Marc-André Gagnon Mercedes García Carrillo CONICET Dialoga Exactas UBA

Our Special Issue: "Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health" Now fully available in Frontiers in Medicine: frontiersin.org/research-topic… #MedicalResearch

Great to see this book out! Deborah Gleeson and I have a chapter on #trade and investment- the reordering of #healthcare and #healthpolicy . Also great chapters by Jenn Lacy-Nichols Marc-André Gagnon Professor Clare Bambra Toby Padilla

Will definitely tune in. Sharon Batt Therapeutics Initiative Dr. Nancy Olivieri Matthew Herder (@mattherder.bksy.social) Marc-André Gagnon Linda Furlini Don Davies

A recent presentation on Bill C-64 for Universal Pharmacare in Canada (For contraceptives and diabetes products). Prescription for Progress? Exploring Canada's New Pharmacare Program youtu.be/o6_lmf4tEfU?si… via YouTube

Pratiques anticoncurrentielles et concentration outrageuse dans la distribution des médicaments de spécialité : l’AQPP dépose une action collective contre certains de ses membres monpharmacien.ca/nouvelles/prat…

How an opioid giant deployed a playbook for moulding doctors’ minds bmj.com/content/385/bm…

So proud of my new ex-PhD student, Dr Robin Shaban Not only they successfully defended their PhD dissertation "A Critical Examination of Efficiency within Competition Law", but they also obtained a Senate Medal for Outstanding Academic Achievement in the process... Bravo Robin!

🥳SPPA's Professor Marc-André has significantly contributed to two new books published by Garnier-Gallimard.📚 librairie-gallimard.com/livre/97824061… librairie-gallimard.com/livre/97824061… These translations bring seminal works of American Institutional Economics to a wider French-speaking audience!👏

My latest paper with Blue Miaoran 董渺然 : a scoping review revealing the secrets of the #chemicalindustry. To increase earning capacity, pervasive conflicts of interests and the systematic production of ignorance are central strategies for this sector. dx.plos.org/10.1371/journa…

Marc-André Gagnon & I just dropped our new open access scoping review, and it’s about how researchers have been digging into internal corporate documents to find out what chemical companies don’t want us to know. 📑: journals.plos.org/plosone/arti... 📑: doi.org/10.1002/cesm.1… #newpaper

Breaking news: My co-authored paper with Marc-André Gagnon has skyrocketed into the top 10% of most-viewed papers in the journal for 2023! 🎉 Thanks to everyone who read it, cited it, or accidentally opened. Hard work wins. Caffeine survives. Sleep? Still pending.